Gene expression signature after one dose of neoadjuvant pembrolizumab associated with tumor response in head and neck squamous cell carcinoma (HNSCC).Eejung Kim, Trisha M. Wise‐Draper, Alice L. Tang et al.|Journal of Clinical Oncology|2018Cited by 4
Neoadjuvant Pembrolizumab is Active in Surgically Resected Head and Neck CancerSarah Palackdharry, Trisha M. Wise‐Draper, Maura L. Gillison et al.|International Journal of Radiation Oncology*Biology*Physics|2018Cited by 1